AC Immune SA (ACIU) Buy or Sell Stock Guide

Last updated: Jul 12, '19

Are you looking for the analysis of AC Immune SA (ACIU) stock? Are you wondering what the bulls and the bears say about it?

If so, you came to the right place. In this stock guide, we will share with you 5 reasons to buy and 3 reasons to sell ACIU stock. You’ll get a perspective on what the bulls and the bears say about it.

The analysis below may be also helpful to you if you have any of the following questions about ACIU stock:

  • Is ACIU a buy or a sell?
  • Should I sell or hold ACIU stock today?
  • Is ACIU a good buy / investment?
  • What are ACIU analyst opinions, recommendations and ratings?

Let’s start with the bull case. Here are the reasons to buy ACIU stock:

1. ACIU quarterly revenue growth was 98.67%, higher than the industry and sector average revenue growth (1.82% and 3.11%, respectively). See ACIU revenue growth chart.

2. ACIU Price/Book ratio is 1.52, and it’s low compared to its industry peers’ P/B ratios. See ACIU forward Price/Book ratio chart.

3. ACIU Price/Sales ratio is 4.39, and it’s low compared to its industry peers’ P/S ratios. See ACIU forward Price/Sales ratio chart.

4. ACIU average analyst rating is Buy. See ACIU analyst rating chart.

5. ACIU average analyst price target ($10.38) is above its current price ($5.29). See ACIU price target chart.

Now that you understand the bull case, let’s look at the reasons to sell ACIU stock (i.e., the bear case):

1. ACIU profitability is declining. The YoY profit margin change was -577.85percentage points. See ACIU profitability chart.

2. ACIU forward P/E ratio is 24.81, and it’s high compared to its industry peers’ P/E ratios. See ACIU forward P/E ratio chart.

3. ACIU short interest (days to cover the shorts) ratio is 5.83. The stock garners more short interest than the average industry, sector or S&P 500 stock. See ACIU short interest ratio chart.

Now let's look at the key statistics for ACIU:

Metrics ACIU
Price $5.46
Average Price Target / Upside $10.38 / 90.11%
Average Analyst Rating Buy
Industry Biotechnology
Sector Healthcare
Number of Employees 86
Market Cap $377.00M
Forward P/E Ratio 25.3807
Price/Book Ratio 4.4421
PEG N/A
Revenue (TTM) $80.78M
YoY Quarterly Revenue Growth 98.66666666666669%
Profit Margin 30.00742758108442%

What are your thoughts on ACIU?

If you liked this analysis, check out Buy or Sell Stock Guides for other stocks.

Comments (0)expand_more